CNTX
Context Therapeutics·NASDAQ
--
--(--)
--
--(--)
7.06 / 10
Outperform
Analyst consensus is strongly bullish: 66.7% Strong Buy and 33.3% Buy from three firms, with a weighted rating of 6.27. Fund‑flow score is 7.86 (good), showing modest overall inflow but mixed size‑specific trends. Despite a 15% price drop, sentiment remains positive.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
67%
Buy
33%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-24
InstitutionPiper Sandler
Times predicted2
Historical Win Rate50.0%
What is the analyst consensus for CNTX?
- CNTX holds a Bullish analyst rating, with 67% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.06/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
